Add BrightSurf on Google Email

DNA-binding fluorescent dyes detect real-time cell toxicity during drug screening

05.30.14 | Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, May 30, 2014—High throughput screening of compounds in live cells is a powerful approach for discovering new drugs, but the potential for cell toxicity must be considered. A novel technique that uses DNA-binding fluorescent dyes to evaluate the cytotoxicity of an experimental compound in real-time during screening, saving time and resources, is described in ASSAY and Drug Development Technologies , a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the ASSAY and Drug Development Technologies website .

Lucius Chiaraviglio and James Kirby, Beth Israel Deaconess Medical Center, evaluated 19 fluorescent DNA-binding dyes and identified four dyes that were not harmful to cells and could not cross the cell membrane if a cell was viable. The authors demonstrated the ability to use these dyes to detect cell death during drug screening in the article " Evaluation of Impermeant, DNA-Binding Dye Fluorescence as a Real-Time Readout of Eukaryotic Cell Toxicity in a High Throughput Screening Format ."

About the Journal

Assay and Drug Development Technologies is an authoritative peer-reviewed journal published 10 times a year in print and online. It provides early-stage screening techniques and tools that enable identification and optimization of novel targets and lead compounds for new drug development. Complete tables of content and a complementary sample issue may be viewed on the ASSAY and Drug Development Technologies website .

About the Publisher

Mary Ann Liebert, Inc., publishers, is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including OMICS: A Journal of Integrative Biology and Genetic Testing and Molecular Biomarkers . Its biotechnology trade magazine, Genetic Engineering & Biotechnology News ( GEN ), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website .

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101

Assay and Drug Development Technologies

Keywords

Article Information

Contact Information

Source

This article is based on a news release from Mary Ann Liebert, Inc./Genetic Engineering News. BrightSurf curates and republishes science news from research institutions worldwide; the original release is linked below.

How to Cite This Article

APA:
Mary Ann Liebert, Inc./Genetic Engineering News. (2014, May 30). DNA-binding fluorescent dyes detect real-time cell toxicity during drug screening. Brightsurf News. https://www.brightsurf.com/news/L55Z3DVL/dna-binding-fluorescent-dyes-detect-real-time-cell-toxicity-during-drug-screening.html
MLA:
"DNA-binding fluorescent dyes detect real-time cell toxicity during drug screening." Brightsurf News, May. 30 2014, https://www.brightsurf.com/news/L55Z3DVL/dna-binding-fluorescent-dyes-detect-real-time-cell-toxicity-during-drug-screening.html.